UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 383

Sortiert nach

Respiratory Syncytial Virus Load, Viral Dynamics, and Disease Severity in Previously Healthy Naturally Infected Children

The Journal of infectious diseases, 2011-10, Vol.204 (7), p.996-1002

2011

Link zum Volltext

Verfügbarkeit prüfen

Immune Responses and Disease Enhancement during Respiratory Syncytial Virus Infection

Clinical Microbiology Reviews, 2005-07, Vol.18 (3), p.541-555

2005

Link zum Volltext

Verfügbarkeit prüfen

Plasticity and Virus Specificity of the Airway Epithelial Cell Immune Response during Respiratory Virus Infection

Journal of Virology, 2012-05, Vol.86 (10), p.5422-5436

2012

Link zum Volltext

Verfügbarkeit prüfen

Thymic stromal lymphopoietin is induced by respiratory syncytial virus–infected airway epithelial cells and promotes a type 2 response to infection

Journal of allergy and clinical immunology, 2012-11, Vol.130 (5), p.1187-1196.e5

2012

Link zum Volltext

Verfügbarkeit prüfen

Respiratory syncytial virus and other respiratory viruses during the first 3 months of life promote a local TH2-like response

Journal of allergy and clinical immunology, 2005-10, Vol.116 (4), p.805-811

2005

Link zum Volltext

Verfügbarkeit prüfen

Circulating Antibody-Secreting Cells during Acute Respiratory Syncytial Virus Infection in Adults

The Journal of infectious diseases, 2010-12, Vol.202 (11), p.1659-1666

2010

Link zum Volltext

Verfügbarkeit prüfen

Resveratrol-Mediated Gamma Interferon Reduction Prevents Airway Inflammation and Airway Hyperresponsiveness in Respiratory Syncytial Virus-Infected Immunocompromised Mice

Journal of Virology, 2011-12, Vol.85 (24), p.13061-13068

2011

Link zum Volltext

Verfügbarkeit prüfen

Association between Common Toll-Like Receptor 4 Mutations and Severe Respiratory Syncytial Virus Disease

The Journal of infectious diseases, 2004-06, Vol.189 (11), p.2057-2063

2004

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic Monoclonal Antibody Treatment Targeting Respiratory Syncytial Virus (RSV) G Protein Mediates Viral Clearance and Reduces the Pathogenesis of RSV Infection in BALB/c Mice

The Journal of infectious diseases, 2009-08, Vol.200 (3), p.439-447

2009

Link zum Volltext

Verfügbarkeit prüfen

Human Respiratory Syncytial Virus Nucleoprotein and Inclusion Bodies Antagonize the Innate Immune Response Mediated by MDA5 and MAVS

Journal of Virology, 2012-08, Vol.86 (15), p.8245-8258

2012

Link zum Volltext

Verfügbarkeit prüfen

Interleukin-27 Inhibits Vaccine-Enhanced Pulmonary Disease following Respiratory Syncytial Virus Infection by Regulating Cellular Memory Responses

Journal of Virology, 2012-04, Vol.86 (8), p.4505-4517

2012

Link zum Volltext

Verfügbarkeit prüfen

Nanobodies®Specific for Respiratory Syncytial Virus Fusion Protein Protect Against Infection by Inhibition of Fusion

The Journal of infectious diseases, 2011-12, Vol.204 (11), p.1692-1701

2011

Link zum Volltext

Verfügbarkeit prüfen

Differential Type I Interferon Induction by Respiratory Syncytial Virus and Influenza A Virus In Vivo

Journal of Virology, 2007-09, Vol.81 (18), p.9790-9800

2007

Link zum Volltext

Verfügbarkeit prüfen

Respiratory syncytial virus infection of airway epithelial cells, in vivo and in vitro, supports pulmonary antibody responses by inducing expression of the B cell differentiation factor BAFF

Thorax, 2013-01, Vol.68 (1), p.76-81

2013

Link zum Volltext

Verfügbarkeit prüfen

Differential Immune Responses and Pulmonary Pathophysiology Are Induced by Two Different Strains of Respiratory Syncytial Virus

The American journal of pathology, 2006-09, Vol.169 (3), p.977-986

2006

Link zum Volltext

Verfügbarkeit prüfen

Specific increase in local IL-17 production during recovery from primary RSV bronchiolitis

Journal of medical virology, 2012-07, Vol.84 (7), p.1084-1088

2012

Link zum Volltext

Verfügbarkeit prüfen

Immunogenicity and efficacy of recombinant RSV-F vaccine in a mouse model

Vaccine, 2007-08, Vol.25 (33), p.6211-6223

2007

Link zum Volltext

Verfügbarkeit prüfen

Expression of Programmed Death–1 Ligand (PD-L) 1, PD-L2, B7-H3, and Inducible Costimulator Ligand on Human Respiratory Tract Epithelial Cells and Regulation by Respiratory Syncytial Virus and Type 1 and 2 Cytokines

The Journal of infectious diseases, 2006-02, Vol.193 (3), p.404-412

2006

Link zum Volltext

Verfügbarkeit prüfen

Immunogenic properties of RSV-B1 fusion (F) protein gene-encoding recombinant adenoviruses

Vaccine, 2009-09, Vol.27 (40), p.5460-5471

2009

Link zum Volltext

Verfügbarkeit prüfen

Viral Respiratory Infection and the Link to Asthma

The Pediatric infectious disease journal, 2008-10, Vol.27 (10 Suppl), p.S97-S103

Gern, James E

2008

Link zum Volltext

Verfügbarkeit prüfen

Protective Efficacy and Immunogenicity of an Adenoviral Vector Vaccine Encoding the Codon-Optimized F Protein of Respiratory Syncytial Virus

Journal of Virology, 2009-12, Vol.83 (23), p.12601-12610

2009

Link zum Volltext

Verfügbarkeit prüfen

Kinetics of the Neutralizing Antibody Response to Respiratory Syncytial Virus Infections in a Birth Cohort

Journal of medical virology, 2013-11, Vol.85 (11), p.2020-2025

2013

Link zum Volltext

Verfügbarkeit prüfen

Respiratory syncytial virus and neutrophil activation

Clinical and experimental immunology, 2005-06, Vol.140 (3), p.470-477

2005

Link zum Volltext

Verfügbarkeit prüfen

Analysis of Respiratory Syncytial Virus Preclinical and Clinical Variants Resistant to Neutralization by Monoclonal Antibodies Palivizumab and/or Motavizumab

The Journal of infectious diseases, 2011-03, Vol.203 (5), p.674-682

2011

Link zum Volltext

Verfügbarkeit prüfen

Effect of Respiratory Syncytial Virus Infection on Plasmacytoid Dendritic Cell Regulation of Allergic Airway Inflammation

International archives of allergy and immunology, 2012-01, Vol.157 (1), p.21-30

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 383

Suche als RSS-Feed

Aktive Filter

SpracheJapanisch

ThemaBiological And Medical Sciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(380)
Mit Volltextzugriff
(369)

Publikationsform

Artikel
(383)

Sprache

Englisch
(383)
Portugiesisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(362)
Life Sciences & Biomedicine
(359)
Humans
(304)
Medical Sciences
(266)
Immunology
(263)
Respiratory Syncytial Virus
(257)
Microbiology
(244)
Fundamental And Applied Biological Sciences. Psychology
(216)
Infectious Diseases
(216)
Female
(159)
Virology
(151)
Viral Diseases
(145)
Infant
(141)
Human Viral Diseases
(135)
Animals
(128)
Male
(127)
Immunology And Allergy
(115)
Viral Diseases Of The Respiratory System And Ent Viral Diseases
(114)
Respiratory Syncytial Virus Infections - Immunology
(98)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Respiratory Syncytial Virus Load, Viral Dynamics, and Disease Severity in Previously Healthy Naturally Infected Children

Immune Responses and Disease Enhancement during Respiratory Syncytial Virus Infection

Plasticity and Virus Specificity of the Airway Epithelial Cell Immune Response during Respiratory Virus Infection

Thymic stromal lymphopoietin is induced by respiratory syncytial virus–infected airway epithelial cells and promotes a type 2 response to infection

Respiratory syncytial virus and other respiratory viruses during the first 3 months of life promote a local TH2-like response

Circulating Antibody-Secreting Cells during Acute Respiratory Syncytial Virus Infection in Adults

Resveratrol-Mediated Gamma Interferon Reduction Prevents Airway Inflammation and Airway Hyperresponsiveness in Respiratory Syncytial Virus-Infected Immunocompromised Mice

Association between Common Toll-Like Receptor 4 Mutations and Severe Respiratory Syncytial Virus Disease

Therapeutic Monoclonal Antibody Treatment Targeting Respiratory Syncytial Virus (RSV) G Protein Mediates Viral Clearance and Reduces the Pathogenesis of RSV Infection in BALB/c Mice

Human Respiratory Syncytial Virus Nucleoprotein and Inclusion Bodies Antagonize the Innate Immune Response Mediated by MDA5 and MAVS

Interleukin-27 Inhibits Vaccine-Enhanced Pulmonary Disease following Respiratory Syncytial Virus Infection by Regulating Cellular Memory Responses

Nanobodies®Specific for Respiratory Syncytial Virus Fusion Protein Protect Against Infection by Inhibition of Fusion

Differential Type I Interferon Induction by Respiratory Syncytial Virus and Influenza A Virus In Vivo

Respiratory syncytial virus infection of airway epithelial cells, in vivo and in vitro, supports pulmonary antibody responses by inducing expression of the B cell differentiation factor BAFF

Differential Immune Responses and Pulmonary Pathophysiology Are Induced by Two Different Strains of Respiratory Syncytial Virus

Specific increase in local IL-17 production during recovery from primary RSV bronchiolitis

Immunogenicity and efficacy of recombinant RSV-F vaccine in a mouse model

Expression of Programmed Death–1 Ligand (PD-L) 1, PD-L2, B7-H3, and Inducible Costimulator Ligand on Human Respiratory Tract Epithelial Cells and Regulation by Respiratory Syncytial Virus and Type 1 and 2 Cytokines

Immunogenic properties of RSV-B1 fusion (F) protein gene-encoding recombinant adenoviruses

Viral Respiratory Infection and the Link to Asthma

Protective Efficacy and Immunogenicity of an Adenoviral Vector Vaccine Encoding the Codon-Optimized F Protein of Respiratory Syncytial Virus

Kinetics of the Neutralizing Antibody Response to Respiratory Syncytial Virus Infections in a Birth Cohort

Respiratory syncytial virus and neutrophil activation

Analysis of Respiratory Syncytial Virus Preclinical and Clinical Variants Resistant to Neutralization by Monoclonal Antibodies Palivizumab and/or Motavizumab

Effect of Respiratory Syncytial Virus Infection on Plasmacytoid Dendritic Cell Regulation of Allergic Airway Inflammation

Aktive Filter

Suchergebnisse filtern